Amgen bought ChemoCentryx ChemoCentryx from 10/20/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Amgen completed its acquisition of ChemoCentryx for $3.7 billion, or $52 per share.

ChemoCentryx

Review

Source:

{source} pictogram

investors.amgen.com

Vladimir Petenev

News editor

Write your comment first

News feed

Bulgarian parliament takes Rosenets oil terminal from Lukoil

7/21/23 LKOH

LSR sales in first half increased by 23.7% in physical terms and by 26.4% in monetary terms

7/21/23 LSRG

VK increases stake in mobile application developer Nota-RTK

7/21/23 VKCO

Himprom reported for 6 months of 2023 by RAS

7/21/23 HIMCP

TGC-1 in first half reduced electricity generation by 6.1%

7/21/23 TGKA

American Express reported for 6 months of 2023

7/21/23 AXP

Novatek to start construction of Murmansk LNG in August 2024

7/21/23 NVTK

Moscow Exchange to launch warehouse value index

7/21/23 MOEX

Novatek plans to supply liquefied gas from Arctic LNG-2 to Japan

7/21/23 NVTK

First line of Arctic LNG-2 went to the installation site

7/21/23 NVTK